The Non-Financial Ledger

This story is about money. It is also about something far more valuable. It is about the trust that people, in their most desperate moments, place in the promise of a cure. Rejuvica LLC sold a product called Sobrenix, marketed as a solution for people struggling with alcohol use disorder. This is a life-or-death battle for millions, a fight that involves intense physical cravings, psychological pain, and social stigma.

Into this arena of suffering, Rejuvica introduced a product built on lies. They sold hope in a bottle, a shortcut that didn’t exist. The real cost is measured in the opportunities for genuine recovery that were lost. Every person who spent their money and time on Sobrenix was a person who could have been seeking evidence-based medical treatment, therapy, or community support. The company’s deception created a dangerous delay, a detour from paths that actually lead to healing.

“Every bottle sold was a betrayal, a cynical transaction that profited from the pain and hope of people fighting for their lives.”

This is the non-financial ledger: the erosion of faith in legitimate treatment, the precious time wasted, and the profound violation of targeting people when they are most vulnerable. The damage done by Rejuvica extends beyond bank accounts; it is etched into the lives of those who were searching for a way out of addiction and were instead sold a dead end.

Legal Receipts

The Federal Trade Commission’s court order permanently bans Rejuvica and its owners from making the very claims they used to build their business. The company is forbidden from claiming, without randomized, double-blind, placebo-controlled human clinical trials, that any product they sell:

A. Reduces or eliminates cravings for alcohol;

B. Enables users to reduce or eliminate their consumption of alcohol;

C. Assists users to regain control of their problematic drinking;

D. Cures, mitigates, or treats any substance use disorder or symptom of a substance use disorder; or

E. Cures, mitigates, or treats any disease;

This is the government cataloging their deception. The order explicitly states that to make such claims in the future, they must possess and rely upon “competent and reliable scientific evidence,” a standard they failed to meet while selling Sobrenix to thousands of people.

Societal Impact Mapping

Public Health

Rejuvica’s business model was a direct threat to public health. By promoting a worthless supplement as a treatment for a serious medical condition, they undermined legitimate medical science and addiction treatment protocols. People with alcohol use disorder require comprehensive care, which can include medically supervised detox, therapy, and approved medications. Promoting snake oil like Sobrenix actively discourages people from seeking this care, potentially worsening their condition and leading to severe health consequences.

Economic Inequality

This scheme extracted wealth from a group of people who are often facing financial instability. Addiction can lead to job loss, debt, and economic hardship. Rejuvica targeted these individuals, convincing them to part with their limited funds for a product with no scientific basis. The $3.2 million judgment represents a direct transfer of wealth from struggling individuals to corporate owners Kyle Armstrong and Kyle Dilger.

The “Cost of a Life” Metric

This isn’t a revenue number. The court documents identify this figure as the amount of “monetary relief” calculated from consumer injury. This is the dollar value of the deception. While Rejuvica and its owners were forced to pay $650,000, the total judgment remains a stark admission of the scale of the harm they inflicted on people seeking help.

What Now?

Accountability requires sustained public pressure. The individuals and systems that enabled this deception must be watched.

Corporate Leadership on Record:

• Kyle Armstrong, Owner, Officer, or Member of Rejuvica LLC
• Kyle Dilger, Owner, Officer, or Member of Rejuvica LLC

Regulatory Watchlist:

• Federal Trade Commission (FTC): This agency brought the case. They are responsible for monitoring Rejuvica for the next 20 years to ensure compliance with the court order. Demand they enforce these settlements to the fullest extent.
• Food and Drug Administration (FDA): The FDA has authority over how dietary supplements are marketed. The rampant fraud in this industry shows a clear need for stronger pre-market approval and enforcement.

The Resistance:

The system is not designed to protect you; it is designed to react after the damage is done. Real power lies in community action.

• Support Mutual Aid: Donate time or resources to local, grassroots organizations that provide direct support for people with substance use disorders. These groups offer real help, not false promises.
• Amplify Truth: Share evidence-based information about addiction treatment. Combat the misinformation spread by predatory companies online and in your community.
• Demand Systemic Change: The dietary supplement industry operates with far too little oversight. Support politicians and policies that call for stricter regulation and hold executives criminally liable for fraudulent health claims that endanger the public.